Pioglitazone (Q31440132)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pioglitazone	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

1 reference

Europe PubMed Central

Pioglitazone (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

author name string

Gillies PS

1

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Dunn CJ

2

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

333-43; discussion 344-5

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone attenuates diet-induced hypertension in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance syndrome: options for treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of thiazolidinediones on expression of UCP2 and adipocyte markers in human PAZ6 adipocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin sensitization in diabetic rat liver by an antihyperglycemic agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone Reduces Smooth Muscle Cell Density of Rat Carotid Arterial Intima Induced by Balloon Catheterization

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes: comparison with pioglitazone and rosiglitazone

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced expression of hexokinase II in insulin-resistant diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin action on protein phosphatase-1 activation is enhanced by the antidiabetic agent pioglitazone in cultured diabetic hepatocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone time-dependently reduces tumour necrosis factor-alpha level in muscle and improves metabolic abnormalities in Wistar fatty rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone Increases Insulin Sensitivity by Activating Insulin Receptor Kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin suppresses apolipoprotein(a) synthesis by primary cultures of cynomolgus monkey hepatocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone enhances splanchnic glucose uptake as well as peripheral glucose uptake in non-insulin-dependent diabetes mellitus. AD-4833 Clamp-OGL Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct vasodepressor effects of pioglitazone in spontaneously hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone (AD-4833) ameliorates insulin resistance in patients with NIDDM. AD-4833 Glucose Clamp Study Group, Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/10983737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200060020-00009

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31440132&oldid=2195116879"